FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 349:903-905 August 28, 2003 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Cheng, Y. PubMed Citation

Recognition of immune thrombocytopenic purpura is increasing because of the increasing frequency of routine blood counts that reveal unexpected thrombocytopenia. For patients who may have immune thrombocytopenic purpura, the essential decisions are whether to perform additional diagnostic studies and whether to initiate any treatment.

The diagnosis of immune thrombocytopenic purpura is established only by ruling out other causes of thrombocytopenia. The patient's history, the findings on physical examination, the blood counts, and the findings on examination of the blood smear are usually sufficient.^1,2 Examination of the blood smear is essential to rule out in vitro platelet clumping that can cause . . . [Full Text of this Article]

Source Information

From the Departments of Medicine and Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, Oklahoma City.

This article has been cited by other articles:

• (2003). Short-Course, High-Dose Steroids for ITP. JWatch General 2003: 1-1 [Full Text]